1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Red blood cell-derived arginase release in hemolytic uremic syndrome
(
- Contribution to journal › Article
- 2013
-
Mark
Complement activation in thrombotic microangiopathy.
(
- Contribution to journal › Scientific review
- 2011
-
Mark
Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome.
(
- Contribution to journal › Article
-
Mark
Successful management of a planned pregnancy in severe congenital thrombotic thrombocytopaenic purpura: the Upshaw-Schulman syndrome.
(
- Contribution to journal › Article
- 2009
-
Mark
Neutrophil-derived proteinase 3 induces kallikrein-independent release of a novel vasoactive kinin
(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation.
(
- Contribution to journal › Article
- 2007
-
Mark
Podocytes express ADAMTS13 in normal renal cortex and in patients with thrombotic thrombocytopenic purpura
(
- Contribution to journal › Article
- 2006
-
Mark
Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets via TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome.
(
- Contribution to journal › Article
- 2001
-
Mark
Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome
(
- Contribution to journal › Article
- 1997
-
Mark
von Willebrand factor mediates increased platelet retention in recurrent thrombotic thrombocytopenic purpura
(
- Contribution to journal › Article